₹1,779.95 12.95 (0.73%)
04:00 PM, 11-Dec-2024₹1,775.30 14.45 (0.82%)
03:48 PM, 11-Dec-2024BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
Last Updated: 11-Dec-2024 | 04:00 PM IST
Market Cap (₹ Cr) | 29,334 |
Traded Value (₹ Cr) | 0.82 |
Volume (Shares) | 4,592 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,590.00 |
52-Week Low Date | 24-Oct-2024 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 29,257 |
EPS - TTM (₹) [C] | 41.98 |
P/E Ratio (X) [C] | 42.29 |
Face Value (₹) | 1 |
Latest Dividend (%) | 2,000.00 |
Latest Dividend Date | 16-Aug-2024 |
Dividend Yield (%) | 1.13 |
Book Value Share (₹) [C] | 533.41 |
P/B Ratio (₹) [C] | 3.33 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 964.92 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 964.92 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 964.92 | 55,51,922 | 1.27 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 964.92 | 55,51,922 | 1.27 |
Mirae Asset Large & Midcap Fund - Regular (G) | 640.85 | 36,87,292 | 1.66 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 640.85 | 36,87,292 | 1.66 |
Mirae Asset Large & Midcap Fund - Direct (IDCW) | 640.85 | 36,87,292 | 1.66 |
Mirae Asset Large & Midcap Fund - Direct (G) | 640.85 | 36,87,292 | 1.66 |
SBI Large & Midcap Fund (IDCW) | 504.02 | 29,00,000 | 1.72 |
SBI Large & Midcap Fund (G) | 504.02 | 29,00,000 | 1.72 |
Load more
Today's Low/High (₹) | 1,756.35 1,788.30 |
Week Low/High (₹) | 1,756.05 1,840.00 |
Month Low/High (₹) | 1,696.10 1,858.00 |
Year Low/High (₹) | 1,585.70 2,221.00 |
All time Low/High (₹) | 861.50 4,350.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -1.39% | -1.42% | 0.70 | 0.71% |
1 Month | -2.36% | -2.35% | 2.55 | 2.07% |
3 Month | -6.06% | -5.98% | 0.00 | -1.11% |
6 Month | -5.57% | -5.35% | 6.63 | 5.92% |
1 Year | -1.45% | -1.42% | 16.58 | 17.36% |
3 Year | -50.64% | -50.69% | 38.68 | 40.72% |
Chairman & Independent Directo : Yiu Kwan Stanley Lau
Managing Director & CEO : SRINIVAS SADU
Non-Exec & Non-Independent Dir : UDO JAHANNES VETTER
Independent Director : C S N Murthy
Independent Director : ESSAJI GOOLAM VAHANVATI
Independent Director : Naina Lal Kidwai
Non-Exec & Non-Independent Dir : Jia Ai (Allen) Zhang
Non Executive Director : Wenjie Zhang
Additional Director : Wei Huang
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,779.95 at 04:00 PM IST on 11th Dec 2024. Gland Pharma Ltd share price was up by 0.73% over the previous closing price of Rs 1,767.00. Gland Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 29,334 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,590.00.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 281.71 crore on a total income of Rs 1,120.79 crore for the quarter ended 2024. For the year ended Sep 2024, Gland Pharma Ltd had posted a profit of Rs 163.53 crore on a total income of Rs 1,465.49 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Piramal Pharma, Suven Pharma, Laurus Labs, Gland Pharma, J B Chemicals &, Natco Pharma, Emcure Pharma.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows: